Literature DB >> 7139651

Phase II trial of PALA in hypernephroma and urinary bladder cancer.

R B Natale, A Yagoda, D P Kelsen, R J Gralla, R C Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7139651

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.

Authors:  M Markman; T C Chan; S Cleary; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.

Authors:  A Yagoda
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Advantages of integrated trials for performing multiple Phase II studies.

Authors:  G B Weiss; J A Hokanson
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.